PT  - JOURNAL ARTICLE
AU  - De Natale, Giuseppe
AU  - De Natale, Lorenzo
AU  - Troise, Claudia
AU  - Marchitelli, Vito
AU  - Coviello, Antonio
AU  - Holmberg, Karen G.
AU  - Somma, Renato
TI  - The evolution of COVID-19 in Italy after the spring of 2020: an unpredicted summer respite followed by a second wave
AID  - 10.1101/2020.08.29.20184127
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.29.20184127
4099  - http://medrxiv.org/content/early/2020/10/30/2020.08.29.20184127.short
4100  - http://medrxiv.org/content/early/2020/10/30/2020.08.29.20184127.full
AB  - The coronavirus (COVID-19) pandemic was particularly invasive in Italy during the period between March and late April 2020 then decreased in both in the number of infections and in the seriousness of the illness throughout the summer of 2020. In this discussion, we measure the severity of the disease by the ratio of Intensive Care Units (ICU) spaces occupied by COVID-19 patients and the number of Active Cases (AC) each month from April to October 2020. We also use the ratio of the number of Deaths (D) to the number of Active Cases. What clearly emerges, from rigorous statistical analysis, is a progressive decrease in both ratios until August, indicating progressive mitigation of the disease. This is particularly evident when comparing March-April with July-August; during the summer period the two ratios became roughly 18 times lower. We test such sharp decreases against possible bias in counting active cases and we confirm their statistical significance. We then interpret such evidence in terms of the well-known seasonality of the human immune system and the virus-inactivating effect of stronger UV rays in the summer. Both ratios, however, increased again in October as ICU/AC began to increase in September 2020. These ratios and the exponential growth of infections in October indicate that the virus - if not contained by strict measures - will lead to unsustainable challenges for the Italian health system in the winter of 2020-2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding supported this researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval is needed for this researchAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are in public repository, both Italian and International